Xeris Biopharma Holdings Inc
NASDAQ:XERS

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Watchlist
Price: 3.05 USD -3.17% Market Closed
Market Cap: 454.5m USD
Have any thoughts about
Xeris Biopharma Holdings Inc?
Write Note

Gross Margin
Xeris Biopharma Holdings Inc

83.7%
Current
77%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
83.7%
=
Gross Profit
151.9m
/
Revenue
181.4m

Gross Margin Across Competitors

Country US
Market Cap 454.3m USD
Gross Margin
84%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 746.8B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 365.6B USD
Gross Margin
69%
Country US
Market Cap 249.1B USD
Gross Margin
77%
Country CH
Market Cap 208.5B CHF
Gross Margin
73%
Country CH
Market Cap 181.2B CHF
Gross Margin
75%
Country UK
Market Cap 159.6B GBP
Gross Margin
82%
Country IE
Market Cap 146B USD
Gross Margin
68%

Profitability Report

View the profitability report to see the full profitability analysis for Xeris Biopharma Holdings Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
83.7%
=
Gross Profit
151.9m
/
Revenue
181.4m
What is the Gross Margin of Xeris Biopharma Holdings Inc?

Based on Xeris Biopharma Holdings Inc's most recent financial statements, the company has Gross Margin of 83.7%.